NASDAQ: DXCM       Dexcom
Last Price Today's Change   Day's Range   Trading Volume
437.66   -9.68 (2.16%)  428.745 - 442.96  322,470


Avg Volume (4 weeks):633,989
4 Weeks Range:428.745 - 579.85
4 Weeks Price Volatility (%):
52 Weeks Range:318.45 - 579.85
52 Weeks Price Volatility (%):
Average Price Target: 48.00
Price Target Upside/Downside: -389.66


No recent Headlines for this stock.

Business Background

Dexcom, Inc. (Dexcom) is a medical device company. The Company is focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for ambulatory use by people with diabetes and for use by healthcare providers. The Company's products consist of DexCom G4 PLATINUM and DexCom G5 Mobile. The Company is commercializing its fifth generation CGM system. The Company's markets DexCom G4 PLATINUM under a Conformite Europeenne Marking (CE Mark), in the European Union, Australia, New Zealand and the countries in Asia and Latin America, and in the United States with approval from the United States Food and Drug Administration (FDA). The DexCom G4 PLATINUM with Share remote monitoring system uses a wireless connection between a patient's receiver and an application on the patient's iPhone, iPod touch, or iPad to transmit glucose information to applications on the mobile devices of designated recipients (followers).

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

1254  3191  175  7375 

Top 10 Active Counters
 ATVI 82.30+16.91 
 F 24.385-0.805 
 ZNGA 9.055+0.095 
 KSU 293.59-5.05 
 AAPL 170.24-2.83 
 CIT 53.50+2.16 
 SRGA 0.88+0.034 
 AMD 134.825-2.055 
 AMC 18.59-1.98 
 T 27.065-0.115